Reuters logo
BRIEF-Clinuvel Pharmaceuticals says FY net profit for the period attributable $7.1 mln
August 30, 2017 / 7:51 AM / 24 days ago

BRIEF-Clinuvel Pharmaceuticals says FY net profit for the period attributable $7.1 mln

Aug 30 (Reuters) - Clinuvel Pharmaceuticals Ltd:

* FY revenues from ordinary activities increased 165 percent to $17.0 million

* FY net profit for the period attributable to members $7.1 million, up 326 percent Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below